Compared with normal samples, OLFML2A had higher expression in 27 cancers, including LUSC, BLCA, DLBC, BRCA, CESC, GBM, COAD, ESCA, KIPR, HNSC, KIRC, LGG, LAML, LUAD, READ, LIHC, PAAD, OV, PRAD, STAD, CHOL, PCPG, SKCM, TGCT, THYM, UCEC, and UCS, shown in Figure 1(a). The gene discussed is OLFML2A; the disease is cancer.